Balancing work & #Caring for a loved one with #Cancer can be challenging. Gain insights from Joanna Fawzy Doran attorney, Joanna Doran, Esq. on navigating this important role as #Caregiver. Read this blog post for actionable tips & helpful resources. brnw.ch/21wICYh

Meet David M. Klaus, a courageous #BladderCancer #Survivor. Read his empowering story of strength and hope and the 7 things he learned during his #CancerTreatment. brnw.ch/21wJ4dZ

🌟 Discover the inspiring story of Mardie Caldwell Christensen and her granddaughter Ellie as they navigate #ChildhoodCancer. From navigating treatments to finding joy amid challenges, their story is a testament to resilience and hope. #EllieTheBrave brnw.ch/21wJb5d

New! #ASCO24 study summary for patients: Estrogen-only menopausal hormone therapy may increase the risk of #OvarianCancer, while combined therapy may not impact this risk and may lower the risk of #UterineCancer brnw.ch/21wK6iy #GYNCSM #Menopause

New! #ASCO24 study summary for patients: #AI-based patient navigation tool may help encourage people in underserved communities receive #ColorectalCancer screening, which can help reduce #CancerDisparities in these patients brnw.ch/21wK6ly #HealthEquity #CancerScreening

New! #ASCO24 study summary for patients: Most #BreastCancer survivors trying to conceive are successful in becoming pregnant and giving birth brnw.ch/21wK6lN #BCSM #Fertility #CancerSurvivorship #CancerandPregnancy

New! #ASCO24 study summary for patients: The #HPV vaccine lowers the risk of developing HPV-related cancers in men and women, especially #HeadandNeckCancer in men and #CervicalCancer in women brnw.ch/21wK6m8 #GYNCSM #HNCSM #CancerPrevention

New! #ASCO24 study summary for patients: Asciminib appears to be a safe and effective treatment option for people recently diagnosed with chronic phase chronic myeloid #Leukemia #CML #LeuSM brnw.ch/21wKkDa

New! #ASCO24 study summary for patients: Lorlatinib can help people with advanced ALK-positive non-small cell #LungCancer who have not yet received treatment live longer without disease progression and prevent brain metastases in some patients brnw.ch/21wKkDI #NSCLC #LCSM

Breaking #ASCO24 news! Study summary for patients: New treatment combination cures classical #Hodgkin lymphoma more effectively and with fewer side effects than an established intensive chemotherapy regimen brnw.ch/21wKljq #lymsm

New from #ASCO24! Study summary for patients: Telehealth #palliative care program is as effective as an in-person palliative care program for people with advanced #LungCancer #LCSM #PallOnc brnw.ch/21wKmqQ

Breaking #ASCO24 news study summary for patients: Chemotherapy before and after surgery improves survival for people with locally advanced #esophageal adenocarcinoma #EsophagealCancer brnw.ch/21wKmqV

New! #ASCO24 study summary for patients: Neoadjuvant #Immunotherapy given for stage III #Melanoma, followed by adjuvant therapy only if there is not a deep response to treatment, improves outcomes for patients #MelSM brnw.ch/21wKmr0

New! #ASCO24 #LAURA study summary for patients: Osimertinib after chemoradiotherapy improves progression-free survival (#PFS) for people with unresectable stage III #EGFRm #NSCLC #LCSM brnw.ch/21wKmr4

Breaking #ASCO24 news! Study summary for patients: Durvalumab after chemoradiotherapy helps people with limited-stage small cell #LungCancer live longer #SCLC #LCSM brnw.ch/21wKmr6

New! #ASCO24 study summary for patients: Some people with advanced #OvarianCancer may safely avoid having their lymph nodes removed during cancer surgery without it impacting survival brnw.ch/21wKmr7 #GYNCSM #OVCSM

New! #ASCO24 study summary for patients: Adding belantamab mafodotin to #MultipleMyeloma treatment combinations appears to be more effective at stopping relapsed disease than current standard treatments #HemOnc brnw.ch/21wKmrf

New! #ASCO24 study summary for patients: Trastuzumab deruxtecan slows cancer growth for people with HR+, HER2-low or HER2-ultralow #MetastaticBreastCancer that has grown following endocrine therapy #MBC #BCSM #BreastCancer brnw.ch/21wKmrF

Breaking #ASCO24 news! Study summary for patients: Docetaxel chemotherapy causes less peripheral #Neuropathy than paclitaxel chemotherapy for Black people with early-stage #BreastCancer #BCSM brnw.ch/21wKnSt